Yellow Forest Fever

Yellow forest fever (syn. Yellow fever jungle) is a viral disease that is transmitted through a mosquito bite and can lead to serious health consequences. It is one of the most dangerous fevers in the world and occurs in tropical and subtropical regions.

Yellow forest fever was first described in 1901 and named for the color of the skin rash that appears on the sufferer's body. It is characterized by high fever, chills, headache, weakness, muscle and joint pain.

The main carrier of the virus is the Aedes aegypti mosquito, which lives in tropical regions of the world. Infection occurs through the bite of a mosquito, which carries the virus in its salivary sac.

Treatment for yellow forest fever includes the use of antibiotics and antiviral drugs. It is also important to maintain hygiene and avoid contact with mosquitoes.

Although yellow forest fever is common in Africa, Asia and South America, it is still a serious threat to human health in many countries around the world. Therefore, it is important to take measures to prevent the spread of this disease and protect the population from mosquito bites.

Jungle fever disease, yellow fever, is an acute anthroponotic infectious disease with cyclical damage to the blood capillaries of the skin and parenchymal organs, clinically manifested by severe intoxication, fever, characteristic rash and damage to blood vessels throughout the body. In patients, the disease occurs in typical and atypical forms.

The typical form is characterized by an intense prodromal period lasting 3-4 days. It occurs with a pronounced clinical picture: * Intoxication: febrile poison remains highly active for a long time, regardless of the period of the disease. Intoxication during tropical yellow fever is distinguished by its malignant nature and becomes the main pathophysiological mechanism of damage to vital organs. The intensity and duration of manifestations of intoxication increases against the background of a decrease in body temperature towards the end of the disease; * Disturbance of the central nervous system: weakness, adynamia, lethargy, drowsiness; * Nervous activity: agitation, insomnia, restlessness, fears, anxiety, hallucinations; * Ophthalmological syndrome: severe lacrimation, pain, photophobia, redness of the eyes, severe swelling and sharp dilation of the pupils; * Dry, intermittent cough;

The transition to the height of the disease occurs unexpectedly, in most cases by the end of the day, the body temperature rises to a maximum of 40°C (rarely rises to 41°C), after a sharp decrease there is no remission. The patient's condition worsens, consciousness becomes confused and coordination of movements is impaired. Severe muscle weakness interferes with swallowing and causes a dry cough